Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_assertion description "[Although anti-CD19 CAR T cells are at an early stage of development, the potent antigen-specific activity observed in patients suggests that infusions of anti-CD19 CAR T cells might become a standard therapy for some B-cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_assertion evidence source_evidence_literature NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_assertion SIO_000772 23546520 NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_assertion wasDerivedFrom befree-20150227 NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_assertion wasGeneratedBy ECO_0000203 NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP642175.RAdvxb5dwvNxc8Ju8zBcl4rOzB4fUrCYmsPCoM1MKXCl0130_provenance.